Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

You may be eligible if

• Have completed the maintenance period of the P09-004 study.
• Continue to be treated with a stable dose of 1 to a maximum of 3 approved concomitant AEDs.